label 138 An open-label, follow-up treatment of additional 6 months was offered to all patients after the controlled, double-blind phase. A total of 176 patients. Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial. Blood. 2021 Nov 25;138(
Keunggulan label 138
- ✅ label 138 Setiap Hari
- ✅ Tanpa Deposit Awal
- ✅ Bisa Dicoba Gratis
LOGIN 
WHATSAPP 
RTP LIVE
LIVECHAT